Your browser doesn't support javascript.
loading
Germline TET2 loss of function causes childhood immunodeficiency and lymphoma.
Stremenova Spegarova, Jarmila; Lawless, Dylan; Mohamad, Siti Mardhiana Binti; Engelhardt, Karin R; Doody, Gina; Shrimpton, Jennifer; Rensing-Ehl, Anne; Ehl, Stephan; Rieux-Laucat, Frederic; Cargo, Catherine; Griffin, Helen; Mikulasova, Aneta; Acres, Meghan; Morgan, Neil V; Poulter, James A; Sheridan, Eamonn G; Chetcuti, Philip; O'Riordan, Sean; Anwar, Rashida; Carter, Clive R; Przyborski, Stefan; Windebank, Kevin; Cant, Andrew J; Lako, Majlinda; Bacon, Chris M; Savic, Sinisa; Hambleton, Sophie.
Afiliación
  • Stremenova Spegarova J; Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Lawless D; Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, United Kingdom.
  • Mohamad SMB; Regenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Penang, Malaysia.
  • Engelhardt KR; Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Doody G; Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, United Kingdom.
  • Shrimpton J; Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, United Kingdom.
  • Rensing-Ehl A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Freiburg, Germany.
  • Ehl S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Freiburg, Germany.
  • Rieux-Laucat F; Université de Paris, Institut Imagine, Paris, France.
  • Cargo C; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, United Kingdom.
  • Griffin H; Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Mikulasova A; Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.
  • Acres M; Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Morgan NV; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Poulter JA; Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, United Kingdom.
  • Sheridan EG; Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, United Kingdom.
  • Chetcuti P; Department of Paediatrics, Leeds General Infirmary, Leeds, United Kingdom.
  • O'Riordan S; Department of Paediatrics, Leeds General Infirmary, Leeds, United Kingdom.
  • Anwar R; Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, United Kingdom.
  • Carter CR; Department of Clinical Immunology and Allergy, St James's University Hospital, Leeds, United Kingdom.
  • Przyborski S; Department of Biosciences, Durham University, Durham, United Kingdom.
  • Windebank K; Wolfson Childhood Cancer Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Cant AJ; Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Lako M; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Bacon CM; Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.
  • Savic S; Wolfson Childhood Cancer Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom.
  • Hambleton S; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.
Blood ; 136(9): 1055-1066, 2020 08 27.
Article en En | MEDLINE | ID: mdl-32518946
Molecular dissection of inborn errors of immunity can help to elucidate the nonredundant functions of individual genes. We studied 3 children with an immune dysregulation syndrome of susceptibility to infection, lymphadenopathy, hepatosplenomegaly, developmental delay, autoimmunity, and lymphoma of B-cell (n = 2) or T-cell (n = 1) origin. All 3 showed early autologous T-cell reconstitution following allogeneic hematopoietic stem cell transplantation. By whole-exome sequencing, we identified rare homozygous germline missense or nonsense variants in a known epigenetic regulator of gene expression: ten-eleven translocation methylcytosine dioxygenase 2 (TET2). Mutated TET2 protein was absent or enzymatically defective for 5-hydroxymethylating activity, resulting in whole-blood DNA hypermethylation. Circulating T cells showed an abnormal immunophenotype including expanded double-negative, but depleted follicular helper, T-cell compartments and impaired Fas-dependent apoptosis in 2 of 3 patients. Moreover, TET2-deficient B cells showed defective class-switch recombination. The hematopoietic potential of patient-derived induced pluripotent stem cells was skewed toward the myeloid lineage. These are the first reported cases of autosomal-recessive germline TET2 deficiency in humans, causing clinically significant immunodeficiency and an autoimmune lymphoproliferative syndrome with marked predisposition to lymphoma. This disease phenotype demonstrates the broad role of TET2 within the human immune system.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Inmunodeficiencia Combinada Grave / Mutación de Línea Germinal / Proteínas de Unión al ADN / Mutación con Pérdida de Función / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Inmunodeficiencia Combinada Grave / Mutación de Línea Germinal / Proteínas de Unión al ADN / Mutación con Pérdida de Función / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos